NCT01120379View on ClinicalTrials.gov

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)

CompletedOBSERVATIONAL
Enrollment

5,034

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2013

Conditions
Chronic Coronary OcclusionVascular DiseaseMyocardial IschemiaCoronary Artery StenosisCoronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Interventions
DEVICE

XIENCE V® EECSS

Single-arm study designed to evaluate XIENCE V® EECSS continued safety and effectiveness during commercial use in real world settings.

Trial Locations (1)

95054

Abbott Vascular, Santa Clara

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY